Minakem Generic APIs Minakem Generic APIs

X

Digital content for Emalex Bioscience

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Emalex Bioscience
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
330 N. Wabash, Suite 3500, Chicago, IL 60611
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.businesswire.com/news/home/20231004005988/en

BUSINESSWIRE
05 Oct 2023

https://www.prnewswire.com/news-releases/emalex-biosciences-announces-first-patient-dosed-in-phase-3-trial-of-ecopipam-for-tourette-syndrome-301759554.html

PR NEWSWIRE
01 Mar 2023

https://www.clinicaltrialsarena.com/news/emalex-biosciences-tourette-syndrome/

CLINICAL TRIALS ARENA
12 Jan 2023

https://www.prnewswire.com/news-releases/emalex-biosciences-publishes-phase-2b-results-for-tourette-syndrome-candidate-in-pediatrics-301719240.html

PR NEWSWIRE
11 Jan 2023

https://www.fiercebiotech.com/biotech/tourette-focused-emalex-rakes-250m-series-d-funding-7x-larger-its-series-c

Gabrielle Masson FIERCEBIOTECH
03 Nov 2022

https://www.prnewswire.com/news-releases/emalex-biosciences-expands-cns-platform-to-advance-treatment-for-restless-legs-syndrome-with-augmentation-301492231.html

PRNEWSWIRE
01 Mar 2022

https://www.prnewswire.com/news-releases/emalex-biosciences-recruiting-people-who-stutter-for-phase-2-clinical-trial-for-childhood-onset-fluency-disorder-301375816.html

PRNEWSWIRE
14 Sep 2021

https://endpts.com/jeff-aronins-emalex-raises-35m-series-c-british-protein-degradation-biotech-emerges-from-stealth/

John Carroll ENDPTS
23 Mar 2021
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY